Levels and values of circulating endothelial progenitor cells, soluble angiogenic factors, and mononuclear cell apoptosis in liver cirrhosis patients

Journal of Biomedical Science

Volumn 19, Issue 1, 2012, Pages

  Chen, Chih Hung ^a   Chang, Li Teh ^b   Tung, Wei Chih ^a   Chen, Yung Lung ^a   Chang, Chia Lo ^a   Leu, Steve ^a   Sun, Cheuk Kwan ^c   Tsai, Tzu Hsien ^a   Tsai, I Ting ^c   Chang, Hsueh Wen ^d   Yip, Hon Kan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b MEIHO UNIVERSITY   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis factors; Cellular apoptosis; Circulating endothelial progenitor cells; Liver cirrhosis

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CD31 ANTIGEN; CD34 ANTIBODY; CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; CXCL12 PROTEIN, HUMAN; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ANGIOGENESIS; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS VARICES; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN CELL; LABORATORY TEST; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ULTRASOUND; BLOOD; CELL DIFFERENTIATION; CYTOLOGY; ENDOTHELIUM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); STEM CELL;

HEPATITIS C VIRUS; HUMAN ECHOVIRUS 1;

ADULT; APOPTOSIS; CELL DIFFERENTIATION; CHEMOKINE CXCL12; ENDOTHELIUM; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES, MONONUCLEAR; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84864650839     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-19-66     Document Type: Article

References (36)

1. Isolation of putative progenitor endothelial cells for angiogenesis. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM, Science 1997 275 964 967 10.1126/science.275.5302.964 9020076 (Pubitemid 27087709)
2. Endothelial progenitor cells as a new agent contributing to vascular repair. Miller-Kasprzak E, Jagodzinski PP, Arch Immunol Ther Exp 2007 55 247 259 10.1007/s00005-007-0027-5 (Pubitemid 47262710)
3. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats. Yip HK, Chang LT, Sun CK, Sheu JJ, Chiang CH, Youssef AA, Lee FY, Wu CJ, Fu M, Crit Care Med 2008 36 873 880 10.1097/CCM.0B013E318165B7EA 18431275
4. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T, Proc Natl Acad Sci USA 2000 97 3422 3427 10725398 (Pubitemid 30183318)
5. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Tendera M, Wojakowski W, Ruzyllo W, Chojnowska L, Kepka C, Tracz W, Musialek P, Piwowarska W, Nessler J, Buszman P, et al. Eur Heart J 2009 30 1313 1321 10.1093/eurheartj/ehp073 19208649
6. Intracoronary autologous CD34+ stem cell therapy for intractable angina. Wang S, Cui J, Peng W, Lu M, Cardiology 2010 117 140 147 10.1159/000320217 20975266
7. Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines. Kocher AA, Schuster MD, Bonaros N, Lietz K, Xiang G, Martens TP, Kurlansky PA, Sondermeijer H, Witkowski P, Boyle A, et al. J Mol Cell Cardiol 2006 40 455 464 10.1016/j.yjmcc.2005.11.013 16438981
8. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells. Huang PH, Chen YH, Wang CH, Chen JS, Tsai HY, Lin FY, Lo WY, Wu TC, Sata M, Chen JW, Lin SJ, Arterioscler Thromb Vasc Biol 2009 29 1179 1184 10.1161/ATVBAHA.109.189175 19461050
9. Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke. Yip HK, Tsai TH, Lin HS, Chen SF, Sun CK, Leu S, Yuen CM, Tan TY, Lan MY, Liou CW, et al. Crit Care 2011 15 40 10.1186/cc10002 21269484
10. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, Dimmeler S, Circulation 2001 103 2885 2890 10.1161/hc2401.092816 11413075 (Pubitemid 32578123)
11. Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system. Wang CH, Verma S, Hsieh IC, Chen YJ, Kuo LT, Yang NI, Wang SY, Wu MY, Hsu CM, Cheng CW, Cherng WJ, J Mol Cell Cardiol 2006 41 34 43 10.1016/j.yjmcc.2006.03.006 16678199 (Pubitemid 43946959)
12. Benefit of combined extracorporeal shock wave and bone marrow-derived endothelial progenitor cells in protection against critical limb ischemia in rats. Yeh KH, Sheu JJ, Lin YC, Sun CK, Chang LT, Kao YH, Yen CH, Shao PL, Tsai TH, Chen YL, et al. Crit Care Med 2012 40 169 177 10.1097/CCM.0b013e31822d74d0 21926605
13. Endothelial and hematopoietic progenitor cells (EPCs and HPCs): hand in hand fate determining partners for cancer cells. Ergün S, Hohn HP, Kilic N, Singer BB, Tilki D, Stem Cell Rev 2008 4 169 177 10.1007/s12015-008-9028-y 18607782
14. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V, Science 2008 319 195 198 10.1126/science.1150224 18187653
15. Endothelial progenitor cells dysfunction and senescence: contribution to oxidative stress. Imanishi T, Tsujioka H, Akasaka T, Curr Cardiol Rev 2008 4 275 286 10.2174/157340308786349435 20066135
16. Endothelial progenitor cells in cardiovascular disorders. Shantsila E, Watson T, Lip GY, J Am Coll Cardiol 2007 49 741 752 10.1016/j.jacc.2006.09.050 17306702
17. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T, N Engl J Med 2003 348 593 600 10.1056/NEJMoa022287 12584367 (Pubitemid 36204953)
18. Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Yip HK, Chang LT, Chang WN, Lu CH, Liou CW, Lan MY, Liu JS, Youssef AA, Chang HW, Stroke 2008 39 69 74 10.1161/STROKEAHA.107.489401 18063830
19. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Valgimigli M, Rigolin GM, Fucili A, Porta MD, Soukhomovskaia O, Malagutti P, Bugli AM, Bragotti LZ, Francolini G, Mauro E, et al. Circulation 2004 110 1209 1212 10.1161/01.CIR.0000136813.89036.21 15249502 (Pubitemid 39202334)
20. Hepatitis C viral RNA in clotting factor concentrates and the development of hepatitis in recipients. Makris M, Garson JA, Ring CJ, Tuke PW, Tedder RS, Preston FE, Blood 1993 81 1898 1902 8384899 (Pubitemid 23101606)
21. Natural history of hepatitis-related hepatocellular carcinoma. But DY, Lai CL, Yuen MF, World J Gastroenterol 2008 14 1652 1656 10.3748/wjg.14.1652 18350595 (Pubitemid 351493370)
22. Angiogenesis soluble factors as hepatocellular carcinoma noninvasive markers for monitoring hepatitis C virus cirrhotic patients awaiting liver transplantation. Mas VR, Maluf DG, Archer KJ, Yanek KC, Fisher RA, Transplantation 2007 84 1262 1271 10.1097/01.tp.0000287596.91520.1a 18049111 (Pubitemid 351339314)
23. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma. Gadelhak NA, Gadelhak SA, El-Morsi DA, Abdelaziz MM, Abbas AT, El-Emshaty HM, Hepatogastroenterology 2009 56 1417 1424 19950803
24. Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic liver is higher when hepatoma is beyond Milan criteria. Aucejo F, Kim R, Zein N, Quintini C, Uso TD, Lopez R, Eghtesad B, Fung J, Miller C, Yerian L, Liver Transpl 2009 15 169 176 10.1002/lt.21678 19177438
25. Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma. Sieghart W, Fellner S, Reiberger T, Ulbrich G, Ferlitsch A, Wacheck V, Peck-Radosavljevic M, Dig Liver Dis 2009 41 902 906 10.1016/j.dld.2009.04.013 19501032
26. Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis. Hung CH, Lu SN, Wang JH, Lee CM, Chen TM, Tung HD, Chen CH, Huang WS, Changchien CS, J Gastroenterol 2003 38 153 157 10.1007/s005350300025 12640529 (Pubitemid 36372290)
27. Relationship of hemodynamic indices and prognosis in patients with liver cirrhosis. Baik SK, Jee MG, Jeong PH, Kim JW, Ji SW, Kim HS, Lee DK, Kwon SO, Kim YJ, Park JW, Chang SJ, Korean J Intern Med 2004 19 165 170 15481608 (Pubitemid 40766808)
28. FibroScan and ultrasonography in the prediction of hepatic fibrosis in patients with chronic viral hepatitis. Wang JH, Changchien CS, Hung CH, Eng HL, Tung WC, Kee KM, Chen CH, Hu TH, Lee CM, Lu SN, J Gastroenterol 2009 44 439 446 10.1007/s00535-009-0017-y 19308312
29. Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis. Kim MY, Baik SK, Yea CJ, Lee IY, Kim HJ, Park KW, Kim HK, Suk KT, Kim JW, Kim HS, et al. Eur J Gastroenterol Hepatol 2009 21 1241 1246 10.1097/MEG. 0b013e32832a21c1 19455045
30. Transection of the oesophagus for bleeding oesophageal varices. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R, Br J Surg 1973 60 646 649 10.1002/bjs.1800600817 4541913
31. Decreased number of circulating CD34+KDR+cells in asymptomatic subjects with preclinical atherosclerosis. Chironi G, Walch L, Pernollet MG, Gariepy J, Levenson J, Rendu F, Simon A, Atherosclerosis 2007 191 115 120 10.1016/j.atherosclerosis.2006.02.041 16620831 (Pubitemid 46237627)
32. Level and value of circulating endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty: in vivo and in vitro studies. Chang HW, Leu S, Sun CK, Hang CL, Youssef AA, Hsieh YK, Yang CH, Cheng CI, Chen SM, Chen CJ, et al. Transl Res 2010 156 251 263 10.1016/j.trsl.2010.07.010 20875902
33. Prognostic value of circulating dead monocytes in patients with acute st-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Tsai TH, Lin YC, Sun CK, Chung SY, Chai HT, Yang CH, Chen SM, Hang CL, Chen CJ, Chua S, et al. Cardiology 2010 117 131 139 10.1159/000320208 20975265
34. Mechanism of endothelial progenitor cell recruitment into neo-vessels in adjacent non-tumor tissues in hepatocellular carcinoma. Yu DC, Chen J, Sun XT, Zhuang LY, Jiang CP, Ding YT, BMC Cancer 2010 10 435 10.1186/1471-2407-10-435 20716344
35. Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha- mediated stellate cell activation. Hong F, Tuyama A, Lee TF, Loke J, Agarwal R, Cheng X, Garg A, Fiel MI, Schwartz M, Walewski J, et al. Hepatology 2009 49 2055 2067 10.1002/hep.22890 19434726
36. Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction. Zeller M, Korandji C, Guilland JC, Sicard P, Vergely C, Lorgis L, Beer JC, Duvillard L, Lagrost AC, Moreau D, et al. Arterioscler Thromb Vasc Biol 2008 28 954 960 10.1161/ATVBAHA.108.162768 18276906 (Pubitemid 351544113)